Observations placeholder
Copaxone
Identifier
023970
Type of Spiritual Experience
Background
A description of the experience
Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone ) is an immunomodulator drug currently used to treat multiple sclerosis. It is a random polymer of four amino acids found in myelin basic protein, namely glutamic acid, lysine, alanine, and tyrosine, and may work as a decoy for the immune system. Glatiramer acetate is approved by the Food and Drug Administration (FDA) for reducing the frequency of relapses, but not for reducing the progression of disability.
Although the clinical definition of multiple sclerosis requires two or more episodes of symptoms and signs, glatiramer acetate is 'approved for treatment after single episodes'. It is also used to treat relapsing-remitting multiple sclerosis. It is administered by subcutaneous injection
On Jan, 31, 2017 26,844 people reported to have side effects when taking Copaxone. Among them, 49 people (0.18%) have Hallucination
On Feb, 02, 2017 26,844 people reported to have side effects when taking Copaxone. Among them, 15 people (0.06%) have Hallucination, Auditory
On Feb, 02, 2017 26,844 people reported to have side effects when taking Copaxone. Among them, 1 person (0.0%) has Hallucination, Tactile
On Jan, 30, 2017 26,844 people reported to have side effects when taking Copaxone. Among them, 503 people (1.87%) have Death